Providing Access to Uncovered Specialty Medications with Paul Pruitt (SHARx)

In this episode of the Empowered Patient Podcast, Paul Pruitt, CGO of SHARx, shares how rising specialty drug costs are putting unsustainable pressure on employer health plans, despite affecting only a small portion of utilization. Employers are increasingly partnering with SHARx to maintain access to critical medications while improving transparency and affordability.